The Point of Care Diagnostics Market is predicted to reach US$ 92.6 billion by 2031 from US$ 28.95 billion in 2020, and to grow at a CAGR of ~11.2% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Products (Glucose Monitoring, Cardiometabolic Monitoring, Pregnancy & Fertility Testing, Infectious Disease Testing, Hematology Testing, Urinalysis Testing, and Drug Abuse Testing), Materials (Hospitals & Critical Care Centers, Outpatient & Ambulatory Care Facilities, and Home Care Settings)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
F. Hoffmann-La Roche Ltd., Abbott, Qiagen, Danaher, BD, Quidel Corporation, Siemens Healthcare Private Limited, Johnson & Johnson Services, Inc., EKF Diagnostics Holdings plc, and Trinity Biotech, among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Point of Care Diagnostics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Point of Care Diagnostics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Point of Care Diagnostics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Point of Care Diagnostics - ANALYSIS & FORECAST, BY REGION
North America Point of Care Diagnostics
1. North America Point of Care Diagnostics , by Country
1. US
2. Canada
1. North America Point of Care Diagnostics , by Product
2. North America Point of Care Diagnostics , by Type
3. North America Point of Care Diagnostics , by Gender
4. North America Point of Care Diagnostics , by Sales Channel
3. Europe Point of Care Diagnostics
1. Europe Point of Care Diagnostics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Point of Care Diagnostics , by Product
3. Europe Point of Care Diagnostics , by Type
4. Europe Point of Care Diagnostics , by Gender
5. Europe Point of Care Diagnostics , by Sales Channel
4. Asia Pacific Point of Care Diagnostics
1. Asia Pacific Point of Care Diagnostics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Point of Care Diagnostics , by product
3. Asia Pacific Point of Care Diagnostics , by Type
4. Asia Pacific Point of Care Diagnostics , by Gender
5. Asia Pacific Point of Care Diagnostics , by Sales Channel
5. Rest of the World Point of Care Diagnostics
1. Rest of the World Point of Care Diagnostics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Point of Care Diagnostics , by Product
3. Rest of the World Point of Care Diagnostics , by Type
4. Rest of the World Point of Care Diagnostics , by Gender
5. Rest of the World Point of Care Diagnostics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 35